Advertisement

Committee Connection

Editorial Board


 
Editor-in-Chief
Jonathan S. Berek, MD, MMS, FASCO, is the Laurie Kraus Lacob Professor and Director of the Stanford Women's Cancer Center at the Stanford Cancer Institute, where he specializes in gynecologic oncology. He is also Chair of the Department of Obstetrics and Gynecology at Stanford University School of Medicine. Dr. Berek currently serves on the Scientific Program Committee and Integrated Media and Technology Committee. He previously served on the Cancer Education Committee and Tumor Markers Expert Panel. He has been Editor-in-Chief of ASCO Connection (previously ASCO News & Forum) since 2004.
   
Al B. Benson III, MD, FASCO, is a Professor of Medicine in the Division of Hematology/Oncology at Northwestern University's Feinberg School of Medicine, Associate Director for Clinical Investigations and Chair of the Clinical Protocol Scientific Review and Monitoring System for the Robert H. Lurie Comprehensive Cancer Center, and an Attending Physician at Northwestern Memorial Hospital. He specializes in gastrointestinal malignancies, including colorectal cancer. He currently serves on the ASCO Cancer Education Committee.
   

Susan Lerner Cohn, MD, is Director of Clinical Sciences, Section of Pediatric Oncology/Hematology, at Comer Children's Hospital at The University of Chicago and a Professor of Pediatrics at The University of Chicago. Dr. Cohn's research interests include pediatric cancers, particularly neuroblastoma, and blood diseases. She is one of a few pediatric oncologists conducting phase I clinical trials of treatments for neuroblastoma. Dr. Cohn has been a member of ASCO since 1988, serving on the Board of Directors, Cancer Education Committee, Cancer Survivorship Committee, Finance Committee, Membership Committee, and the Strategic Planning Committee. She currently serves on the Cancer.Net Editorial Board.
   

Sabha Ganai, MD, PhD, is Director of Gastrointestinal Oncology at the Simmons Cancer Institute at Southern Illinois University. Her research interests have focused on translational research related to the mechanisms of metastasis, as well as ethics education. She has been an active member of the ASCO University Fellows Council since 2010 and currently serves on the ASCO Integrated Media and Technology Committee. Follow Dr. Ganai on Twitter @DrSabha.
   
Stuart A. (Skip) Grossman, MD, is a Professor of Oncology, Medicine, and Neurosurgery at the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center. His clinical interests include developing novel therapeutic strategies for patients with primary and metastatic brain tumors, leptomeningeal metastases, and cancer pain.
   
Stephen Leong, MD, an ASCO member since 2005, is an Associate Professor of the Division of Medical Oncology in the School of Medicine at the University of Colorado. Prior to this appointment, he completed his fellowship at the University of Colorado, obtained a master degree in Medical Science from the University College Dublin, completed his residency at Albert Einstein Medical Center in Philadelphia and graduated and interned at the Royal College of Surgeons in Ireland. His areas of interest are gastrointestinal malignancies and developmental therapeutics, where he focuses on investigating novel agents in colorectal cancers.
   

Robert G. Mennel, MD, FASCO, specializes in medical oncology and hematology at Texas Oncology-Baylor Charles A. Sammons Cancer Center in Dallas, Texas. Dr. Mennel is board certified in both internal medicine and medical oncology; his primary research interests are head and neck cancers. He has been a member of ASCO since 1980, serving on the Breast Cancer Tumor Markers Committee, Gastrointestinal Tumor Markers Committee, Cancer Education Committee, and Oncology Training Programs Committee.
   

Hope S. Rugo, MD, is a medical oncologist and hematologist specializing in breast cancer research and treatment at the University of California, San Francisco. She is also a Professor of Medicine, Director of the Breast Oncology and Clinical Trials Education, and is the principal investigator of multiple clinical trials focusing on combining novel targeted therapeutics with standard treatment to improve the treatment of both early and late stage breast cancer. Dr. Rugo has been a member of ASCO since 1994, serving on the Scientific Program Committee and Membership Committee.

 

Alan Sandler, MD, is Principal Medical Director for Genetech. He is the author or co-author of more than 200 published articles, book chapters, reviews, and abstracts involving the pharmacology and clinical activity of chemotherapy and novel targeted agents, with a particular emphasis on lung cancer. He has been a member of ASCO since 1993, serving on the Cancer Education Committee and the Scientific Program Committee.

 

Jennifer S. Temel, MD, an ASCO member since 2002, is the Clinical Director of Thoracic Oncology and the Associate Director of the Dana Farber/Partners Cancer Care Hematology/Oncology Fellowship at Massachusetts General Hospital. Prior to this appointment, she completed her fellowship at the Dana Farber Cancer Institute, performed her residency at Brigham and Women's Hospital, and graduated from the Washington University School of Medicine in St. Louis. Her research area of interest is quality of life and symptom management in patients with advanced cancer.